JTCVS Techniques最新文献_第9页

Open ascending aorta replacement combined with fenestrated total aortic arch stenting 开放升主动脉置换术联合开窗全主动脉弓支架植入术

IF 1.7

JTCVS Techniques Pub Date : 2025-03-08 DOI: 10.1016/j.xjtc.2025.03.002

Xiantao Ma MD, PhD , Zhangqiang Zhu MD , Yi Feng MD , Chenhe Li MD , Ningxin Hou MD , Cai Cheng MD, PhD

{"title":"Open ascending aorta replacement combined with fenestrated total aortic arch stenting","authors":"Xiantao Ma MD, PhD , Zhangqiang Zhu MD , Yi Feng MD , Chenhe Li MD , Ningxin Hou MD , Cai Cheng MD, PhD","doi":"10.1016/j.xjtc.2025.03.002","DOIUrl":"10.1016/j.xjtc.2025.03.002","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this retrospective single-center study was to report a novel hybrid technique of replacement of the ascending aorta and implantation of fenestrated stent-graft of the entire aortic arch for Stanford type A aortic dissection and to analyze clinical experience and outcomes.</div></div><div><h3>Methods</h3><div>From January 2019 to January 2023 in Tongji hospital, 31 cases (26 men and 5 women, mean age 56.06 ± 10.34 years) with Stanford type A aortic dissection underwent open ascending aorta replacement combined with total endovascular arch repair. All patients underwent ascending aorta replacement without hypothermia or circulatory arrest. Arch intervention was performed with self-modified stent-grafts to preserve the aortic arch native branches.</div></div><div><h3>Result</h3><div>The surgical technical success rate was 100% in all patients. One (3.22%) patient died after surgery due to cerebral hemorrhage. Five (16.13%) patients with preoperative renal insufficiency required hemodialysis. Six (19.36%) patients were on mechanical ventilation for more than 48 hours. One patient was found to have an endoleak (Type IV). There were 25 (83.33%) patients who underwent follow-up with a median follow-up time of 14.00 months (range, 6.50-28.50 months). Two (8.00%) of them died (1 of infectious shock and the other of respiratory arrest) and 2 (8.00%) underwent aortic reoperation.</div></div><div><h3>Conclusions</h3><div>Single-stage open ascending aortic replacement combined with the total aortic endovascular arch intervention may provide satisfactory early outcomes in Stanford type A aortic dissection. This strategy may be valuable for a subgroup of patients deemed inappropriate candidates for open classic full arch repair.</div></div>","PeriodicalId":53413,"journal":{"name":"JTCVS Techniques","volume":"31 ","pages":"Pages 11-17"},"PeriodicalIF":1.7,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144169007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Resection and reconstruction of the left atrium with cardiopulmonary bypass for T4 non–small cell lung cancer 体外循环切除和重建左心房治疗T4非小细胞肺癌

IF 1.7

JTCVS Techniques Pub Date : 2025-03-08 DOI: 10.1016/j.xjtc.2025.01.029

Lin Zhou MD , Zhipeng Hao MD , Kun Huang PhD , Yuchen Chen MD, PhD , Ni Zhang MD , Xiangning Fu MD , Yangkai Li MD, PhD

{"title":"Resection and reconstruction of the left atrium with cardiopulmonary bypass for T4 non–small cell lung cancer","authors":"Lin Zhou MD , Zhipeng Hao MD , Kun Huang PhD , Yuchen Chen MD, PhD , Ni Zhang MD , Xiangning Fu MD , Yangkai Li MD, PhD","doi":"10.1016/j.xjtc.2025.01.029","DOIUrl":"10.1016/j.xjtc.2025.01.029","url":null,"abstract":"<div><h3>Objective</h3><div>Radical surgery for T4 non–small cell lung cancer, especially for those tumors invading the heart, poses a significant challenge for thoracic surgeons, as demonstrated by the paucity of previous reports. This study aimed to report our surgical technique and experience with this radical surgery that necessitated cardiopulmonary bypass and to assess the prognosis of these patients with locally advanced non–small cell lung cancer.</div></div><div><h3>Methods</h3><div>This study included 4 patients with non–small cell lung cancer (enrolled between 2010 and 2020) who underwent en bloc tumor resection and reconstruction of the left atrium with cardiopulmonary bypass. The clinical features, preoperative assessment, surgical technique, and outcomes of these patients were reviewed.</div></div><div><h3>Results</h3><div>All patients received complete R0 resection and reconstruction. The mean operative and cardiopulmonary bypass times were 370.5 ± 100.7 minutes and 20.3 ± 13.8 minutes, respectively. One patient died within 30 days after surgery, 2 patients died 46 days and 7 months postoperatively, and 1 patient is still alive 47 months postoperatively without recurrence or metastasis.</div></div><div><h3>Conclusions</h3><div>In the contemporary era of targeted and immunotherapy, surgical intervention may offer a viable alternative for patients with T4 NSCLC involving the left atrium who have exhibited resistance to neoadjuvant therapeutic regimens.</div></div>","PeriodicalId":53413,"journal":{"name":"JTCVS Techniques","volume":"31 ","pages":"Pages 169-176"},"PeriodicalIF":1.7,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144169005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Corrigendum to ‘A simplified approach to robotic tracheal resection’ [JTCVS Techniques Volume 27, October 2024, P176-178] “机器人气管切除的简化方法”的勘误表[JTCVS技术第27卷，2024年10月，P176-178]

IF 1.7

JTCVS Techniques Pub Date : 2025-03-08 DOI: 10.1016/j.xjtc.2025.03.001

David Rice MB, BCh , Mohanad Elsheikh MD , Elena Potylchansky MD

引用次数: 0

Double apical cannulation technique for the implantation of an extracorporeal left ventricular assist device 体外左心室辅助装置植入的双根尖插管技术

IF 1.7

JTCVS Techniques Pub Date : 2025-03-06 DOI: 10.1016/j.xjtc.2025.02.014

Ai Kawamura MD, PhD, Takuji Kawamura MD, PhD, Daisuke Yoshioka MD, PhD, Yusuke Misumi MD, PhD, Shin Yajima MD, PhD, Shunsuke Saito MD, PhD, Takashi Yamauchi MD, PhD, Kazuo Shimamura MD, PhD, Shigeru Miyagawa MD, PhD

引用次数: 0

Reconstruction of left pulmonary vein using the left atrial appendage after resection of the common trunk 左心房附件切除肺动脉主干后重建左肺静脉

IF 1.7

JTCVS Techniques Pub Date : 2025-03-05 DOI: 10.1016/j.xjtc.2025.02.012

Yosuke Motoharu MD , Masatoshi Yamaoka MD , Ryuji Hojo MD , Eiichi Teshima MD , Ryuji Tominaga MD, PhD

引用次数: 0

Totally endoscopic replacement of the ascending aorta with 3-dimensional visualization: Defining “totally endoscopic?” A case report 全内镜下升主动脉三维可视化置换：定义“全内镜下”？病例报告

IF 1.7

JTCVS Techniques Pub Date : 2025-03-05 DOI: 10.1016/j.xjtc.2025.02.010

Pham Tran Viet Chuong MD, PhD , Phan Quang Thuan MD , Ho Duc Thang MD , Lam Dac Huy MD , Tran Minh Bao Luan MD, PhD , Nguyen Hoang Dinh MD, PhD

引用次数: 0

The Y-incision with a new roof technique to enlarge the aortic root y型切口采用新顶技术扩大主动脉根部

IF 1.7

JTCVS Techniques Pub Date : 2025-03-05 DOI: 10.1016/j.xjtc.2025.02.013

Guan-Xi Wang MD, PhD, Sen Zhang MD, PhD, Fei Xu MD, PhD

引用次数: 0

Tracheostomy can be avoided! Anterior-posterior cricoid split in bilateral vocal fold paralysis following complex congenital heart surgery 气管切开术可以避免！复杂先天性心脏手术后双侧声带麻痹的环状膜前后分裂

IF 1.7

JTCVS Techniques Pub Date : 2025-03-05 DOI: 10.1016/j.xjtc.2025.02.011

Grant Chappell BS , Muhammad Faateh MBBS , Douglas von Allmen MD , David G. Lehenbauer MD , Michael J. Rutter MD , Awais Ashfaq MD

引用次数: 0

Rare coronary anomaly in association with tetralogy of Fallot and absent pulmonary valve 罕见的冠状动脉异常与法洛四联症和肺动脉瓣缺失有关

IF 1.7

JTCVS Techniques Pub Date : 2025-02-28 DOI: 10.1016/j.xjtc.2025.02.007

T.K.Susheel Kumar MD , Zoe Underill MD , Cynthia Harrison MD , Sujata B. Chakravarti MD , Michael J. Martinez MD , Michael Argilla MD , Ralph Mosca MD

引用次数: 0

Successful use of bivalirudin in neonates for postoperative aortopulmonary shunt thrombosis prevention 比伐鲁定在新生儿术后预防心肺分流血栓形成中的成功应用

IF 1.7

JTCVS Techniques Pub Date : 2025-02-28 DOI: 10.1016/j.xjtc.2025.02.006

Rhynn J. Soderstrom PharmD , Elizabeth C. Chernuta CPNP , Nadia Chaudhry-Waterman DO , Jennifer A. Rafter CPNP , Matthew L. Stone MD, PhD , John S. Kim MD

{"title":"Successful use of bivalirudin in neonates for postoperative aortopulmonary shunt thrombosis prevention","authors":"Rhynn J. Soderstrom PharmD , Elizabeth C. Chernuta CPNP , Nadia Chaudhry-Waterman DO , Jennifer A. Rafter CPNP , Matthew L. Stone MD, PhD , John S. Kim MD","doi":"10.1016/j.xjtc.2025.02.006","DOIUrl":"10.1016/j.xjtc.2025.02.006","url":null,"abstract":"<div><h3>Objectives</h3><div>We aim to describe the successful use of bivalirudin for immediate postoperative aortopulmonary shunt thrombosis prevention. This article also describes the details of an institutional protocol for postoperative aortopulmonary shunt thrombosis prevention. In addition, we demonstrate the safe and effective use of low-molecular-weight heparin and aspirin for interstage thrombosis prevention.</div></div><div><h3>Methods</h3><div>Retrospective cohort study of neonates (excluding infants younger than age 1 day and older than age 28 days) undergoing stage 1 single-ventricle palliation with either a modified Blalock Taussig Thomas or central shunt over a 2-year period.</div></div><div><h3>Results</h3><div>Eighteen consecutive neonates were studied, 11 patients after modified Blalock Taussig Thomas shunt and 7 after central shunt. All patients were initiated on bivalirudin infusion of 0.2 mg/kg/h. Patients remained within the target partial thromboplastin time range of 50 to 70 seconds a median of 97% of the time. None of the 18 patients had shunt thrombosis during the first 21 days after surgery. There were 2 patients who experienced late shunt thrombosis (61 and 27 days), prompting the addition of low-molecular-weight heparin to aspirin after transition from bivalirudin. With low-molecular-weight heparin and aspirin, there were no further shunt thromboses and all patients survived to second-stage surgery.</div></div><div><h3>Conclusions</h3><div>Bivalirudin is a safe and effective alternative to unfractionated heparin for immediate postoperative aortopulmonary shunt thrombosis prevention. Transition to low-molecular-weight heparin and aspirin resulted in effective and safe thrombosis prevention through the second-stage surgery. This regimen resulted in no bleeding complications in this cohort of 18 infants.</div></div>","PeriodicalId":53413,"journal":{"name":"JTCVS Techniques","volume":"31 ","pages":"Pages 152-157"},"PeriodicalIF":1.7,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144167645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0